EX-10.27 33 dex1027.htm DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT DPT LABORATORIES, LTD. AND PEPLIN, INC. **** Certain confidential information contained in this document, marked with four asterisks, has been...Development and Clinical Supply Agreement • May 5th, 2020 • New Jersey
This Development And Manufacturing Agreement (this “Agreement”), effective as of this October 23, 2007 (the “Effective Date”), is made by and between Peplin, Inc., a Delaware corporation with its principal place of business at 6475 Christie Avenue, Emeryville, California 94608 (“COMPANY”), and DPT Laboratories, Ltd., a Texas Limited Partnership with its principal place of business at 307 E. Josephine, San Antonio, Texas 78215 (“DPT”).
DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT DPT Laboratories, Ltd. And Peplin, Inc.Development and Clinical Supply Agreement • December 28th, 2007 • Peplin Inc • Pharmaceutical preparations • New Jersey
This Development And Manufacturing Agreement (this “Agreement”), effective as of this October 23, 2007 (the “Effective Date”), is made by and between Peplin, Inc., a Delaware corporation with its principal place of business at 6475 Christie Avenue, Emeryville, California 94608 (“COMPANY”), and DPT Laboratories, Ltd., a Texas Limited Partnership with its principal place of business at 307 E. Josephine, San Antonio, Texas 78215 (“DPT”).
Change Order Form - Amendment 5*Development and Clinical Supply Agreement • October 24th, 2011 • Radius Health, Inc. • Blank checks
Description of change: Radius has asked 3M to prepare three Workplans that identify activities that could be initiated in February 2011. These activities are summarized on the following Workplans:
Amendment 1 (“this Amendment”) to the Development and Clinical Supply Agreement with the Contract Number: E86A1D4C-B3F9Development and Clinical Supply Agreement • March 27th, 2015 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations
The Parties amend their Development and Clinical Supply Agreement with the Contract Number: E86A1D4C-B3F9, effective as of 31 August 2012, (“the Agreement”) as follows:
Development and Clinical Supply Agreement Contract Number: E86A1D4C-B3F9 Between Rentschler Biotechnologie GmbH - and - Ultragenyx Pharmaceutical Inc.Development and Clinical Supply Agreement • November 8th, 2013 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
